Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Katowice
Clinical trial register · Poland

Clinical Trials in Katowice, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 44 Bydgoszcz 42 Lublin 36 Krakow 36 Gdansk 30
Narrow the registerReset
Recruitment status
Phase
Site location
Warsaw44 Bydgoszcz42 Lublin36 Krakow36 Gdansk30
All 60 locations
Target enrolment
to

Trials with a site in Katowice

17 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Bydgoszcz, Gdansk, Katowice, Lublin, Warsaw, Wałbrzych
2026-05-31
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Bydgoszcz, Bytom, Katowice, Krakow, Nadarzyn, Nowa Sól, Poznan, Płońsk
2026-03-05
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Bydgoszcz, Katowice, Krakow, Lublin, Nowy Targ, Olsztyn, Opole, Poznan
2025-10-01
Active, closed
Janssen Research & Development, LLC
Phase 3
752
Bialystok, Elblag, Katowice, Krakow, Lodz, Olsztyn, Poznan, Skierniewice
2025-04-15
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Bydgoszcz, Gdansk, Gorlice, Grudziądz, Katowice, Leszno, Poznan, Warsaw
2024-07-25
Active, closed
Janssen Research & Development, LLC
Phase 1
108
Biała Podlaska, Gdansk, Katowice, Kielce, Lublin, Wroclaw
2024-06-07
Active, closed
A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
NCT06470438Lymphoma, Non-Hodgkin, Refractory B-Cell NHL, Relapsed B-cell NHL
Janssen Research & Development, LLC
Phase 1
58
Katowice, Kielce, Skorzewo
2024-05-28
Active, closed
Janssen Research & Development, LLC
Phase 3
731
Bialystok, Katowice, Kielce, Krakow, Olsztyn, Warsaw, Wroclaw
2024-03-09
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Gdansk, Katowice, Kielce, Lublin
2023-03-29
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Bialystok, Bolesławiec, Bydgoszcz, Chelmie, Działdowo, Grodzisk Mazowiecki, Gryfice, Katowice
2023-02-15
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Biała Podlaska, Brzozów, Bydgoszcz, Katowice, Kielce, Lodz, Lublin, Poznan
2022-10-25
Recruiting
Janssen Research & Development, LLC
Phase 3
199
Bydgoszcz, Katowice, Krakow, Lublin, Warsaw
2021-07-15
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Bialystok, Gdansk, Katowice, Lodz, Opole, Warsaw
2019-08-15
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Bydgoszcz, Chojnice, Częstochowa, Gdansk, Gdynia, Jelenia Góra, Katowice, Krakow
2018-04-13
Rows per page Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-poland/city/katowice

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 17 of those studies with a site in Katowice that also match the filters currently applied.

How many clinical trials are recruiting in Katowice?

7 of the 17 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Katowice), 17 studies
PhaseStudiesRecruitingShare
Phase 313776.5%
Phase 12011.8%
Phase 2/32011.8%

Most active sponsors

Lead sponsors with the most studies (Katowice)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC177
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.